Ambarella: Back To Reality

Ambarella beat FQ3 results, but the management team suggested revenues of $10 million were pulled forward.
After years of spending, the company still can't disclose any needle moving CV chip deals with automotive customers.
The stock is likely to retest $40 with revenue estimates for FY20 and FY21 declining.
Despite all of the promises of computer vision chips and the huge stock rally this year, Ambarella (NASDAQ:AMBA) still hasn't generated anywhere near the results and forward expectations warranting the stock rally this year. Investors should expect the stock to come back down to earth based on my previous research due to falling expectations for the next couple of years consistent with the past of this chip company and risks of basically operating in China.
Read the full article on Seeking Alpha. 

Disclosure: No position. Please review the disclaimer page for more details. 

Comments

Popular posts from this blog

Camping World: Momentum Stinks

Aurora Cannabis: Deal Or No Deal